Exposure to Mycobacterium tuberculosis (MTB) in a renal transplant candidate: What further preoperative screening tests are available?

Clinical Transplantation

Volumn 11, Issue 2, 1997, Pages 142-148

  Felger, Jason ^a   Halff, Glenn A ^a   Esterl Jr , Robert M ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Antituberculous chemotherapy; Living related renal transplantation; Tuberculous lymphadenitis

Indexed keywords

ANTIBIOTIC AGENT;

ADULT; ARTICLE; CASE REPORT; FEMALE; HEMODIALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY TRANSPLANTATION; LIVING DONOR; MORBIDITY; MYCOBACTERIOSIS; MYCOBACTERIUM TUBERCULOSIS; NEPHRECTOMY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SCREENING TEST; TUBERCULOUS LYMPHADENITIS;

FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; INTRAOPERATIVE PERIOD; KIDNEY TRANSPLANTATION; LIVING DONORS; LYMPH NODES; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PREOPERATIVE CARE; RADIOGRAPHY, THORACIC; TUBERCULIN TEST; TUBERCULOSIS; TUBERCULOSIS, LYMPH NODE; TUBERCULOSIS, PULMONARY;

EID: 0030887418     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. THORNTON GF. Extrapulmonary tuberculosis, excluding the central nervous system. In: ROSSMAN MD, MACGREGOR RR, eds. Tuberculosis: Clinical Management and New Challenges. New York: McGraw Hill 1995: 173.
2. HUMPHRIES MJ, LAM WK, TEOH R. Non-respiratory tuberculosis. In: DAVIES PDO, ed. Clinical Tuberculosis. London: Chapman and Hall 1994: 93.
3. WIER MR, THORNTON GF. Extrapulmonary tuberculosis: experience of a community hospital and review of the literature. Am J Med 1985: 79: 467.
4. KENT DC. Tuberculous lymphadenitis: not a localized disease process. Am J Med Sci 1967: 254: 866.
5. POWELL DA. Tuberculous lymphadenitis. In: SCHLOSSBERG D, ed. Tuberculosis. New York: Springer-Verlag 1983: 99.
6. WINN RE, MEIER PA. Extrapulmonary tuberculosis. In: HOEPRICH PD, JORDAN MC, RONALD AR, eds. Infectious Disease: A Treatise of Infectious Processes. Philadelphia: J B Lippincott 1994: 465.
7. METHA JB, DUTT A, HARVILL L, MATHEWS KM. Epidemiology of extrapulmonary tuberculosis. Chest 1991: 99: 1134.
8. DANDAPAT MC, MISHRA BM, DASH SP, KAR PK. Peripheral lymph node tuberculosis: a review of 80 cases. Br J Surg 1990: 771: 911.
9. HOPEWELL PC. Overview of clinical tuberculosis. In: BLOOM BR, ed. Tuberculosis: Pathogenesis, Protection and Control. Washington DC: ASM Press 1994: 32.
10. ALVAREZ S, MCCABE WR. Extrapulmonary tuberculosis revised: a review of experience at Boston City and other hospitals. Medicine 1984: 63: 25.
11. HUHTI E, BRANDER E, PLOHEIMO S. Tuberculosis of the cervical nodes: a clinical, pathological and bacteriological study. Tubercle 1975: 56: 27.
12. CITRON KM, GIRLING DJ. Tuberculosis. In: WEATHERALL DJ, LEDINGHAM JGG, WARRELL DA, eds. Oxford Textbook of Medicine. Oxford: Oxford University Press 1987: 5.278.
13. LAU SK, WEI WI, HSU C, ENGZELL UC. Fine needle aspiration biopsy of tuberculous cervical lymphadenopathy. Aust N Z J Surg 1988: 58: 947.
14. LAU SK, WEI WI, KWAN S, YEW WW. Combined use of fine-needle cytologic examination and tuberculin skin test in the diagnosis of cervical tuberculous lymphadenitis: a prospective study. Arch Otolaryngol Head Neck Surg 1991: 117: 87.
15. LAU SK, WEI WI, HSU C, ENGZELL UC. Efficacy of fine-needle aspiration cytology in the diagnosis of tuberculous cervical lymphadeaopathy. J Laryngol Otol 1990: 104: 24.
16. SHAHA A, WEBBER C, MARTI J. Fine-needle aspiration in the diagnosis of cervical lymphadenopathy. Am J Surg 1986: 152: 420.
17. PRAT L, BAJIN MT, RICART Y, ROCA M, MORA J, MARTIN-COMIN J. Gallium 67-citrate and Tc99m HMPAO leukocyte scanning in extrapulmonary tuberculosis. Clin Nucl Med 1991: 16: 865.
18. SANTTN M, et al. Utility of the gallium 67-citrate scan for the early diagnosis of tuberculosis in patients infected with the human immunodeficiency virus. Clin Infect Dis 1995: 20: 652.
19. YANG SO, et al. Detection of extrapulmonary tuberculosis with gallium 67-citrate scan and computed tomography. J Nucl Med 1992: 33: 2118.
20. COUSER JI JR, GLASSROTH J. Tuberculosis. An epidemic in older adults. Clin Chest Med 1993: 14: 491.
21. CAMPBELL IA, DYSON AJ. Lymph node tuberculosis: a comparison of treatments 18 months after completion of chemotherapy. Tubercle 1979: 60: 95.
22. BRITISH THORACIC SOCIETY RESEARCH COMMITTEE. Short course chemotherapy for tuberculosis of the lymph nodes: a controlled trial. Brit Med J 1985: 290: 1106.
23. BRITISH THORACIC SOCIETY RESEARCH COMMITTEE. Short course chemotherapy for lymph node tuberculosis: final report a 5 years. Brit J Dis Chest 1988: 82: 274.
24. CHEN YM, LEE PY, PERNG RP. Lymph node tuberculosis: 7-year experience in Veterans General Hospital, Taipei, Taiwan. Tuber Lung Dis 1992: 73: 368.
25. ORMEROD LP. A retrograde comparison of two drug regimens RHE2/RH10 and RHZ2/RH10 in the treatment of tuberculous mediastinal lymphadenopathy. Brit J Dis Chest 1988: 82: 274.
26. MCCARTHY OR, RUDD RM. Six months' chemotherapy for lymph node tuberculosis. Respir Med 1989: 83: 425.
27. JAWAHAR MS, SIVASUBRAMANIAN S, VIJAYAN VK. Short course chemotherapy for tuberculous lymphadenitis in children. Brit Med J 1990: 301: 359.
28. CAMPBELL IA, ORMEROD LP, FRIEND JA, JENKINS PA, PRESCOTT RJ. Six months versus nine months chemotherapy for tuberculosis of the lymph nodes: final results. Respir Med 1993: 87: 621.
29. Editorial. Tuberculosis in patients having dialysis. Brit Med J 1980: 280: 349.
30. SASAKI S, et al. Ten years' survey of dialysis-associated tuberculosis. Nephron 1979: 24: 141.
31. RUTSKY EA, ROSTAND SG. Mycobacteriosis in patients with chronic renal failure. Arch Intern Med 1980: 140: 57.
32. PETERS TG, REITER CG, BOSWELL RL. Transmission of tuberculosis by kidney transplantation. Transplantation 1984: 38: 514.
33. PRADHAN RP, KATZ LA, NIDUS BD, MATALON R, EISINGER RP. Tuberculosis in dialyzed patients. J Am Med Assoc 1974: 229: 798.
34. GARCIA-LEONI ME, MARTIN-SCAPA C, RODENO P, VALDERRABANO F, MORENO S, BOUZA E. High incidence of tuberculosis in renal patients. Eur J Clin Microbiol Infect Dis 1990: 9: 283.
35. MORI MA, LEONARDSON G, WELTY TK. The benefits of isoniazid chemoprophylaxis and risk factors for tuberculosis among Oglala Sioux Indians. Arch Intern Med 1992: 152: 547.
36. RIEDER HL, CAUTHEN GM, COMSTOCK GW, SNIDER DE. Epidemiology of tuberculosis in the United States. Epidemiol Rev 1989: 11: 79.
37. HUSSEIN MM, MOOIJ JVM, ROUJOULEH H, EL-SAYED H. Observations in a Saudi-Arabian dialysis population over a 13-year period. Nephrol Dial Transplant 1994: 9: 1072.
38. JOHN GT, THOMAS PP, THOMAS M, JEYASEELAN L, JACOB CK, SHASTRY JCM. A double-blind randomized controlled trial of primary isoniazid prophylaxis in dialysis and transplant patients. Transplantation 1994: 57: 1683.
39. LLORACH M. Overlooked tuberculosis in chronic haemodialysis patients. Nephron 1980: 25: 301.
40. LEVENTHAL Z, GAFTER U, ZEVIN D, TURANI H, LEVI J. Tuberculosis in patients on hemodialysis. Isr J Med Sci 1982: 18: 245.
41. MCWHINNEY N, KHAN O, WILLIAMS G. Tuberculosis in patients undergoing maintenance haemodialysis and renal transplantation. Br J Surg 1981: 68: 408.
42. RIFKIND D, MARCHIORO TL, WADDELL WR, STARZL TE. Infectious disease associated with renal homotransplantation. J Am Med Assoc 1964: 189: 397.
43. NEFF TA, HUDGEL DW. Miliary tuberculosis in a renal transplant recipient American Review of Respiratory Diseases 1973: 108: 677.
44. EVANS DB. Successful treatment of tuberculosis in renal transplant recipients. J R Soc Med 1978: 71: 458.
45. BELL TJ, WILLIAMS GB. Successful treatment of tuberculosis in renal transplant recipients. J R Soc Med 1978: 71: 265.
46. LUNDIN AP, ADLER AJ, BERLYNE GM, FRIEDMAN EA. Tuberculosis in patients undergoing maintenance hemodialysis. Am J Med 1979: 67: 597.
47. PAPADIMITRIOU M, MEMMOS D, METAXAS P. Tuberculosis in patients on regular hemodialysis. Nephron 1979: 24: 53.
48. BELCON MC, SMITH EKM, KAHANA LM, SHIMIZI A. Tuberculosis in dialysis patients. Clin Nephrol 1982: 17: 14.
49. THOMAS PA, MANKO MA. Chemoprophylaxis for the prevention of tuberculosis in the immunosuppressed renal allograft recipient. Transplantation 1975: 20: 76.
50. KWAN JTC, HART PD, RAFTERY MJ, CUNNINGHAM J, MARSH FP. Mycobacterial infection is an important infective complication in British Asian dialysis patients. J Hosp Infect 1991: 19: 249.
51. Editorial. Tuberculosis in chronic renal failure. Lancet 1980: 1: 909.
52. BOWERSOX DW, WINTEBAUER RH, STEWART GL, ORME B, BARRON E. Isoniazid dosage in patients with renal failure. N Engl J Med 1973: 289: 84.
53. LICHTENSTEIN IH, MACGREGOR RR. Mycobacterial infections in renal transplant recipients: report of five cases and review of the literature. Rev Infect Dis 1983: 5: 216.
54. LLOVERAS J, PETERSON P, SIMMONS RL, NAJARIAN JS. Mycobacterial infections in renal transplant recipients. Arch Intern Med 1982: 142: 888.
55. QUNIBI WY, et al. Mycobacterial infection after renal transplantation-report of 14 cases and review of the literature. Q J Med 1990: 282: 1039.
56. EDWARDS OM, COURTENAY-EVANS RJ, GALLEY JM, HUNTER J, TAIT AD. Changes in cortisol metabolism following rifampin therapy. Lancet 1974: 2: 549.
57. MC ALLISTER WAC, THOMPSON PJ, AL-HABET SM, ROGERS HJ. Rifampin reduces effectiveness and bioavailability of prednisolone. Brit Med J 1983: 286: 923.
58. COCKBURN I. Cyclosporin A: a clinical evaluation of drug interactions. Transpl Proc 1986: 18: 50.
59. VAN BUREN D, et al. The antagonistic effect of rifampin upon cyclosporine bioavailability. Transpl Proc 1984: 16: 1642.
60. OFFERMANN G, KELLER F, MOLZAHN M. Low cyclosporine A blood levels and acute graft rejection in a renal transplant recipient during rifampin treatment Am J Nephrol 1985: 5: 385.
61. BUFFINGTON GA, DOMINGUEZ JH, PIERING WF, HEBERT LA, KAUFFMAN HM JR, LEMANN J JR. Interaction of rifampin and glucocorticoids-adverse effect on renal allograft function. J Am Med Assoc 1976: 17: 1958.